Revenue for the quarter was $1.83 million with operating income of $61.42 million.
The Seattle, Washington (WA)-based company operating in the pharmaceutical preparations sector has total shareholders equity of $412.39 million.
Also read:
This is a developing story. Click
here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts
here.